Show simple item record

dc.contributor.authorMagwanga, Richard Odongo
dc.contributor.authorOnyang, Benson
dc.contributor.authorOchieng, Alfred
dc.contributor.authorAwandu, Shehu Shagari
dc.contributor.authorWere, Pamella
dc.contributor.authorKirungu, Joy Nyangasi
dc.contributor.authorOloo, Marceline Adhiambo
dc.contributor.authorMuok, Erick
dc.contributor.authorMunga, Stephen
dc.contributor.authorOgutu, Fredrick
dc.contributor.authorOrwa, Angeline
dc.contributor.authorOkumu, Fredrick
dc.contributor.authorOnyango, Clayton
dc.contributor.authorAwuor, Dorothy
dc.contributor.authorOrata, Francis
dc.contributor.authorMideg, Justine Ochieng’-
dc.contributor.authorOure, Bonface
dc.contributor.authorNyunja, Regina
dc.contributor.authorAde, Fredrick
dc.contributor.authorIndechi, Shirley
dc.contributor.authorOkuto, Erick
dc.contributor.authorEstambale, Benson
dc.date.accessioned2024-04-22T12:16:34Z
dc.date.available2024-04-22T12:16:34Z
dc.date.issued2022-09-28
dc.identifier.urihttps://doi.org/10.20944/preprints202209.0439.v1
dc.identifier.urihttp://ir-library.mmust.ac.ke:8080/xmlui/handle/123456789/2803
dc.description.abstractCoronavirus is a disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which emerged as a global pandemic in 2019 from Wuhan, China. Since its emergence, it has caused immense suffering to human life, 6.27 million lives have been lost, movement curtailed and social dynamics disrupted. The golden standard for getting samples for SARS-CoV-2 detection is through oral- nasopharyngeal swab, this method of sample collection is invasive and uncomfortable, thus stigmatized the general population, and thereby impeded the progress of controlling the spread through mass testing. Being a contact disease, mechanisms to encourage mass testing is key to reduce the spread. This study thus developed a complimentary sample type to test for SARS-CoV-2, the use of human feces. Fecal samples were collected from 100 asym-symptomatic individuals suspected to be infected with COVID-19, virus RNA was then extracted and profiled through Real Time Polymerase Chain Reaction (RT-qPCR). The antigen rapid diagnostic test revealed high positivity rate of 44%, but the real time polymerase chain reaction results on nasopharyngeal and fecal samples revealed a significant variation, high number of the patients tested positive with stool samples compared to the nasopharyngeal swabs, with 43 and 37%, respectively. SARS-CoV-2 virus was detected in both symptomatic and asymptomatic individuals; however, the symptomatic registered a higher positivity of 25% compared to 20% among the asymptomatic patients. Vaccination only lowered the risk of infection, fully and partially vaccinated lowered the infection level to 10% compared to 20% among the unvaccinated. Finally, gender parity in relation to COVID19 was evaluated, more females (56%) compared to males were recruited in this study, out of which (20; 43.4%) were positive, and 26 (56.6%) were negative based on fecal RT-qPCR outcomes. Based on the outcome of this study, rapid diagnostic test (Ag-RDT) however cheap and or fast does not provide accurate information, moreover, the virus does not stay longer within the Oro-nasopharyngeal region, thus the invalid or negative results, thus use of feces should be adopted as a confirmatory test to ascertain the COVID19 status of an individual.en_US
dc.language.isoenen_US
dc.publisherEurope PMCen_US
dc.subjectSARS-CoV-2, Detection, Fecal, Samples,Sym-asymptotic, Patients, Typical, Findings, COVID-19, Ag-RDT, SARS-CoV-2, RT-PCR, Testsen_US
dc.titleSARS-CoV-2 Detection in Fecal Samples in Sym-asymptotic Patients with Typical Findings of COVID-19 on Ag-RDT and SARS-CoV-2 RT-PCR Testsen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record